IMF tells Reeves to drop triple lock pension and make ‘fundamental’ tax reform Economics The UN’s global financial fund has called on Chancellor Rachel Reeves to drop the triple lock pension and draw up “contingency” tax measures to ensure that public debt is reduced as a share of GDP. The International Monetary Fund has said that there are “risks” around spending forecasts and tax receipts, criticising the Chancellor for [...]
Labour’s leadership Phoney War continues, this time as farce Opinion Labour is conducting Schrodinger’s leadership election and it’s increasingly looking like I, Claudius performed b y the cast of Up Pompeii, says Eliot Wilson Following Labour’s punishment beatings in the local and devolved parliamentary elections, the guerrilla war over Sir Keir Starmer’s leadership of the party has finally erupted into open warfare. Or has it? [...]
The story of Keir Starmer’s failure is boringly familiar Opinion Keir Starmer’s fate was not brought about chiefly by his lack of personality. It was the predictable result of the economic conditions that have wracked Britain for almost two decades, a political system poorly attuned to fixing them, and more than a little of his own hubris, says Andrew Griffith Analysing why Keir Starmer failed [...]
British Gas to cough up £20m for ‘unfair treatment’ of vulnerable customers May 15, 2026 British Gas is set to cough up £20m after the watchdog closed an investigation into the energy giant and found it “fell short in its treatment of an unacceptable number of vulnerable customers”. The investigation looked into British Gas’ treatment of customers who had prepayment meters (PPMs) installed without permission, with consumers set to benefit [...]
The Capitalist: City AM dirty stop outs blame the Guildhall lost and found May 14, 2026 Andy Burnham, X-rated typos and trouble at the Guildhall lost and found; catch up on the latest City gossip in The Capitalist.
Pension fund snaps up cut-price government bonds amid Starmer sell-off May 13, 2026 One of the UK’s largest pension funds has jumped on the turmoil that speculation over Keir Starmer’s future has unleashed on the gilt market, scooping up government bonds at multi-decade low valuations. Standard Life has added to its holding of UK government debt, City AM understands, seizing on a sharp dip in the of the [...]
ICON expands US early phase research capabilities with new clinic and outpatient centres May 13, 2026 New, 69.5K square-foot, state-of-the-art clinic in Texas integrates clinical, laboratory, and pharmacy infrastructure all under one roof Two new satellite outpatient clinics in Texas and Kansas will further expand recruitment reach and reduce visit burden
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights May 13, 2026 FDA granted Compass NDA rolling submission and review request, based on strength of Phase 3 data CNPV awarded for COMP360 in TRD, further accelerating momentum 26-week (Part B) data from COMP006, expected in early Q3 2026 Final NDA submission on track for Q4, aligned with Company’s previously defined accelerated timing to be launch ready by end of year Successful financing and warrant exercises resulted in strong cash position of $466 million at end of first quarter, providing cash runway well beyond launch and into 2028
AI’s biggest problem is that it is trained to ‘please you’, warns tech chief May 13, 2026 The biggest risk facing AI may be that it becomes too good at telling users what they want to hear. Anthony Goonetilleke, chief tech officer at software firm Amdocs, told City AM businesses rushing to deploy AI are vastly underestimating a more subtle and potentially more dangerous problem emerging inside LLMs. “There’s another bucket I [...]
Alkermes Announces Positive Topline Results From REVITALYZ℠ Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia May 12, 2026 – LUMRYZ Met All Primary and Key Secondary Endpoints Demonstrating Statistically Significant and Clinically Meaningful Improvements Compared to Placebo in Excessive Daytime Sleepiness and Patient-Reported Disease Severity – – Safety Profile Consistent With Known Safety Profile of LUMRYZ –